Royal Bank of Canada’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,304
| Closed | -$68K | – | 7733 |
|
|
2024
Q1 | $68K | Sell |
4,304
-16,115
| -79% | -$248K | ﹤0.01% | 5394 |
|
|
2023
Q4 | $329K | Buy |
20,419
+8,722
| +75% | +$111K | ﹤0.01% | 4651 |
|
|
2023
Q3 | $148K | Buy |
11,697
+3,602
| +44% | +$49.7K | ﹤0.01% | 5073 |
|
|
2023
Q2 | $114K | Buy |
8,095
+1,824
| +29% | +$26.1K | ﹤0.01% | 5229 |
|
|
2023
Q1 | $97K | Sell |
6,271
-2,727
| -30% | -$45.5K | ﹤0.01% | 5205 |
|
|
2022
Q4 | $147K | Buy |
8,998
+8,433
| +1,493% | +$137K | ﹤0.01% | 5162 |
|
|
2022
Q3 | $10K | Buy |
565
+312
| +123% | +$4.9K | ﹤0.01% | 6440 |
|
|
2022
Q2 | $3K | Sell |
253
-2,190
| -90% | -$24.2K | ﹤0.01% | 6882 |
|
|
2022
Q1 | $23K | Sell |
2,443
-6,080
| -71% | -$51.7K | ﹤0.01% | 6535 |
|
|
2021
Q4 | $83K | Buy |
8,523
+8,004
| +1,542% | +$151K | ﹤0.01% | 6070 |
|
|
2021
Q3 | $18K | Buy |
519
+474
| +1,053% | +$15.1K | ﹤0.01% | 6753 |
|
|
2021
Q2 | $2K | Sell |
45
-2,119
| -98% | -$82K | ﹤0.01% | 7275 |
|
|
2021
Q1 | $97K | Buy |
2,164
+2,139
| +8,556% | +$99.6K | ﹤0.01% | 5491 |
|
|
2020
Q4 | $1K | Buy |
+25
| New | +$1.48K | ﹤0.01% | 6989 |
|
|
2020
Q3 | – | Sell |
-35
| Closed | -$2K | – | 7027 |
|
|
2020
Q2 | $2K | Sell |
35
-975
| -97% | -$52.2K | ﹤0.01% | 6327 |
|
|
2020
Q1 | $41K | Sell |
1,010
-938
| -48% | -$52.1K | ﹤0.01% | 5261 |
|
|
2019
Q4 | $121K | Buy |
+1,948
| New | +$92.6K | ﹤0.01% | 4989 |
|
|
2019
Q3 | – | Sell |
-341
| Closed | -$8K | – | 7240 |
|
|
2019
Q2 | $8K | Buy |
+341
| New | +$7.98K | ﹤0.01% | 6129 |
|
|
2018
Q4 | – | Sell |
-266
| Closed | -$10K | – | 7222 |
|
|
2018
Q3 | $10K | Buy |
266
+208
| +359% | +$7.69K | ﹤0.01% | 5998 |
|
|
2018
Q2 | $2K | Buy |
+58
| New | +$1.71K | ﹤0.01% | 6283 |
|
|
2018
Q1 | – | Sell |
-81
| Closed | -$2K | – | 6902 |
|
|
2017
Q4 | $2K | Buy |
+81
| New | +$1.59K | ﹤0.01% | 6311 |
|
Other funds holding DCPH
Royal Bank of Canada's DCPH Position: Q2 2024 in Review
Royal Bank of Canada sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 4,304 shares — an estimated $68K sold.
Royal Bank of Canada first reported a position in DCPH in Q4 2017 and held it in 21 quarters. The position peaked at $329K in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Royal Bank of Canada reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Royal Bank of Canada sold 4,304 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $68K.
- Royal Bank of Canada first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 21 quarters.
- Royal Bank of Canada's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $329K in Q4 2023.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.